Clinical Trial Update: Phase I Study of the BBP-398 in Patients With Advance Solid Tumors [Phase 1]

View source ↗

Summary

Phase I study of BBP-398 in patients with advanced solid tumors, including advanced or metastatic non-small cell lung cancer, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BBP-398

Snippet

Sponsor: LianBio LLC | Conditions: Advanced Solid Tumor, Advanced or Metastatic Non-small Cell Lung Cancer | Phase 1 | Status: TERMINATED